| Journal Profile | |||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Journal Title | Cancer Nanotechnology | ||||||||||||||||||||||||||||
| Journal Title Abbreviations | CANCER NANOTECHNOL | ||||||||||||||||||||||||||||
| ISSN | 1868-6958 | ||||||||||||||||||||||||||||
| E-ISSN | 1868-6966 | ||||||||||||||||||||||||||||
| h-index | N.A. | ||||||||||||||||||||||||||||
| CiteScore |
| ||||||||||||||||||||||||||||
| Self-Citation Ratio (2020-2021) | 1.90% | ||||||||||||||||||||||||||||
| 期刊简介 | Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum. | ||||||||||||||||||||||||||||
| Official Website | https://www.springer.com/journal/12645 | ||||||||||||||||||||||||||||
| Online Manuscript Submission | https://www.editorialmanager.com/CANO | ||||||||||||||||||||||||||||
| Open Access | Yes | ||||||||||||||||||||||||||||
| Publisher | CAMPUS, 4 CRINAN ST, LONDON, ENGLAND, N1 9XW | ||||||||||||||||||||||||||||
| Subject Area | Pharmacology, Toxicology and Pharmaceutics | ||||||||||||||||||||||||||||
| Country/Area of Publication | AUSTRIA | ||||||||||||||||||||||||||||
| Publication Frequency | |||||||||||||||||||||||||||||
| Year Publication Started | 2010 | ||||||||||||||||||||||||||||
| Annual Article Volume | 83 | ||||||||||||||||||||||||||||
| Gold OA文章占比 | |||||||||||||||||||||||||||||
| OA期刊相关信息 | |||||||||||||||||||||||||||||
| WOS期刊SCI分区 | |||||||||||||||||||||||||||||
| Indexing (SCI or SCIE) | Science Citation Index Expanded | ||||||||||||||||||||||||||||
| Link to PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1868-6958%5BISSN%5D | ||||||||||||||||||||||||||||
| Average Duration of Peer Review * | Authorized Data from Publisher: Data from Authors: 15 Weeks | ||||||||||||||||||||||||||||
| Competitiveness * | Data from Authors: | ||||||||||||||||||||||||||||
| Useful Links |
| ||||||||||||||||||||||||||||
| *All review process metrics, such as acceptance rate and review speed, are limited to our user-submitted manuscripts. As such they may not reflect the journals' exact competitiveness or speed. | |||||||||||||||||||||||||||||
| |
| First Previous 1 Next Last (To Page | |
| Reviews on Cancer Nanotechnology: | Write a review |
| Author: sunnybitc Subject Area: Medicine Duration of Peer Review: 2.0 month(s) Result: Accepted after revision Write a review |
Reviewed 2022-05-30 23:38:29 Height increases quickly, the proof is also fast. However, the online typesetting is relatively slow, and it is possible that it will not be published until three months later. The layout fee is 12,000, which is a bit expensive. The impact factor is expected to rise, and it feels okay.  (0) Thank | sunnybitc  |
| Author: sunnybitc Subject Area: Medicine Duration of Peer Review: 1.0 month(s) Result: Pending & Unknown Write a review |
Reviewed 2022-01-07 10:21:24 The impact factor is good, and it is steadily increasing. I have submitted it and hope for good results. (1) Thank | sunnybitc |
| First Previous 1 Next Last (To Page | |